Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Chappell

Showing results (41-50 of 162) with videos related to

Pageof 17
Sort By:
Journal of Cardiovascular Pharmacology|December 13, 2018
Comparison of Candesartan and Angiotensin-(1-7) Combination to Mito-TEMPO Treatment for Normalizing Blood Pressure and Sympathovagal Balance in (mREN2)27 RatsManisha Nautiyal, Hossam A Shaltout, Mark C Chappell, et al.
Therapeutic Advances in Cardiovascular Disease|June 18, 2009
Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis ratJewell A Jessup, Brian M Westwood, Mark C Chappell, et al.
Hypertension (Dallas, Tex. : 1979)|January 5, 2012
Angiotensin-(1-7) deficiency and baroreflex impairment precede the antenatal Betamethasone exposure-induced elevation in blood pressureHossam A Shaltout, James C Rose, Mark C Chappell, et al.
Peptides|February 20, 2022
Angiotensinogen uptake and stimulation of oxidative stress in human pigment retinal epithelial cellsVictor M Pulgar, Nildris Cruz-Diaz, Brian M Westwood, et al.
Journal of Cardiovascular Pharmacology|February 18, 2011
Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female ratSarah H Lindsey, Kyle A Carver, Eric R Prossnitz, et al.
American Journal of Physiology. Cell Physiology|September 24, 2005
Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytesPatricia E Gallagher, Mark C Chappell, Carlos M Ferrario, et al.
Contributions to Nephrology|July 14, 2004
Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulationMark C Chappell, J Gregory Modrall, Debra I Diz, et al.
Hypertension (Dallas, Tex. : 1979)|January 5, 2021
Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1-7) and Angiotensin II in Human PlasmaMark C Chappell, Nancy T Pirro, Andrew M South, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 20, 2014
The ins and outs of angiotensin processing within the kidneyBryan A Wilson, Allyson C Marshall, Ebaa M Alzayadneh, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 6, 2015
Sex-Specific Changes in Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Gene Expression and Enzyme Activity at Birth and Over the First Year of LifeKai Chen, Jianli Bi, Yixin Su, et al.
Pageof 17

Showing results (41-50 of 162) with videos related to

Sort By:
Pageof 17
Journal of Cardiovascular Pharmacology|December 13, 2018
Comparison of Candesartan and Angiotensin-(1-7) Combination to Mito-TEMPO Treatment for Normalizing Blood Pressure and Sympathovagal Balance in (mREN2)27 RatsManisha Nautiyal, Hossam A Shaltout, Mark C Chappell, et al.
Therapeutic Advances in Cardiovascular Disease|June 18, 2009
Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis ratJewell A Jessup, Brian M Westwood, Mark C Chappell, et al.
Hypertension (Dallas, Tex. : 1979)|January 5, 2012
Angiotensin-(1-7) deficiency and baroreflex impairment precede the antenatal Betamethasone exposure-induced elevation in blood pressureHossam A Shaltout, James C Rose, Mark C Chappell, et al.
Peptides|February 20, 2022
Angiotensinogen uptake and stimulation of oxidative stress in human pigment retinal epithelial cellsVictor M Pulgar, Nildris Cruz-Diaz, Brian M Westwood, et al.
Journal of Cardiovascular Pharmacology|February 18, 2011
Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female ratSarah H Lindsey, Kyle A Carver, Eric R Prossnitz, et al.
American Journal of Physiology. Cell Physiology|September 24, 2005
Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytesPatricia E Gallagher, Mark C Chappell, Carlos M Ferrario, et al.
Contributions to Nephrology|July 14, 2004
Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulationMark C Chappell, J Gregory Modrall, Debra I Diz, et al.
Hypertension (Dallas, Tex. : 1979)|January 5, 2021
Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1-7) and Angiotensin II in Human PlasmaMark C Chappell, Nancy T Pirro, Andrew M South, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 20, 2014
The ins and outs of angiotensin processing within the kidneyBryan A Wilson, Allyson C Marshall, Ebaa M Alzayadneh, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 6, 2015
Sex-Specific Changes in Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Gene Expression and Enzyme Activity at Birth and Over the First Year of LifeKai Chen, Jianli Bi, Yixin Su, et al.
Pageof 17